LEP and metabolic syndrome: Since leptin is almost exclusively secreted from adipocytes and obesity is associated with increased leptin serum concentrations which potentially contribute to insulin resistance and metabolic syndrome [29], this adipocytokine deserves further attention as potential comorbidity biomarker of cardiovascular risk (see Figure 1).